- Quantification of BCR-ABL Transcripts by Real-Time PCR in Leukemia Samples2004 | First Faculty of Medicine
- Importance of quantitative evaluations of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia2006 | First Faculty of Medicine
- Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with Imatinib mesylate for chronic or accelerated disease phase2004 | Publication without faculty affiliation
- Quantification of BCR-ABL Transcripts by Real-Time PCR in Leukemia Samples2004 | Faculty of Medicine in Hradec Králové
- Availability of a real-time RT-PCR method for relative quantification of BCR-ABL transcriptsPublication without faculty affiliation
- Evaluation of real-time RT-PCR used for relative quantification of BCR-ABL transcripts in leukemia patientsPublication without faculty affiliation
- Our Four-Year Experience with Real-Time PCR Analysis Used for Quantification of BCR-ABL Transcripts in Haematological PatientsPublication without faculty affiliation
- Importance of quantitative evaluations of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia +12006 | Faculty of Medicine in Hradec Králové
- The Kinetics of BCR-ABL Transcript Levels in CML Patients in Chronic ar Accelerated Phase during Imatinib Mesylate TreatmentPublication without faculty affiliation
- CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib2005 | First Faculty of Medicine
- CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib2005 | Faculty of Physical Education and Sport
- Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis2005 | Central Library of Charles University
- Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis2005 | First Faculty of Medicine
- Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis2005 | Faculty of Physical Education and Sport
- Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL12019 | Second Faculty of Medicine
- Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?2001 | Central Library of Charles University, Second Faculty of Medicine
- Molecular monitoring of responses to DLI and DLI+IFN treatment of post-SCT relapses in patients with CML2003 | Second Faculty of Medicine
- Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring2009 | Second Faculty of Medicine
- Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia2016 | Second Faculty of Medicine
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Location of the BCR/ABL fusion genes on both chromosomes 9q34 in Ph negative chronic myeloid leukemia2002 | First Faculty of Medicine, Third Faculty of Medicine